Skip to contentK
Kewaunee Scientific Corp
K
KEQUKewaunee Scientific Corp Q1 2022 · 10-Q
Revenue$39.49M$39.49M+8.4% vs Q1 2021 Net Income-$1.35M-$1.35MN/M vs Q1 2021 EPS Diluted-$0.48-$0.48N/M vs Q1 2021 Gross Profit$5,674,000−3.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kewaunee Scientific Corp · CIK 55529 · Engraved from SEC EDGAR
Operating Cash Flow-$1,776,000N/M Free Cash Flowderived-$2,260,000N/M Margins · derivedGross margin14.4%−1.8 pt vs Q1 2021
Operating margin-2.8%−2.0 pt vs Q1 2021
Net margin-3.4%−1.8 pt vs Q1 2021
ended Jul 31, 2021 · filed Sep 10, 2021 · 41 d after period end